These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24194847)

  • 1. Transgenic rabbits that overexpress the neonatal Fc receptor (FcRn) generate higher quantities and improved qualities of anti-thymocyte globulin (ATG).
    Baranyi M; Cervenak J; Bender B; Kacskovics I
    PLoS One; 2013; 8(10):e76839. PubMed ID: 24194847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the rabbit neonatal Fc receptor (FcRn) and analyzing the immunophenotype of the transgenic rabbits that overexpresses FcRn.
    Catunda Lemos AP; Cervenak J; Bender B; Hoffmann OI; Baranyi M; Kerekes A; Farkas A; Bosze Z; Hiripi L; Kacskovics I
    PLoS One; 2012; 7(1):e28869. PubMed ID: 22247762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FcRn Overexpression Expands Diversity of the Humoral Immune Response in bFcRn Transgenic Mice.
    Szikora B; Marx A; Jani PK; Pipek O; Müller V; Csabai I; Kacskovics I
    Front Immunol; 2020; 11():1887. PubMed ID: 32973781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerating antibody discovery using transgenic animals overexpressing the neonatal Fc receptor as a result of augmented humoral immunity.
    Cervenak J; Kurrle R; Kacskovics I
    Immunol Rev; 2015 Nov; 268(1):269-87. PubMed ID: 26497527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic expression of bovine neonatal Fc receptor in mice boosts immune response and improves hybridoma production efficiency without any sign of autoimmunity.
    Schneider Z; Cervenak J; Baranyi M; Papp K; Prechl J; László G; Erdei A; Kacskovics I
    Immunol Lett; 2011 Jun; 137(1-2):62-9. PubMed ID: 21338624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NFκB induces overexpression of bovine FcRn: a novel mechanism that further contributes to the enhanced immune response in genetically modified animals carrying extra copies of FcRn.
    Cervenak J; Doleschall M; Bender B; Mayer B; Schneider Z; Doleschall Z; Zhao Y; Bősze Z; Hammarström L; Oster W; Kacskovics I
    MAbs; 2013; 5(6):860-71. PubMed ID: 24492342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FcRn overexpression in mice results in potent humoral response against weakly immunogenic antigen.
    Végh A; Cervenak J; Jankovics I; Kacskovics I
    MAbs; 2011; 3(2):173-80. PubMed ID: 21239891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies.
    Kacskovics I; Cervenak J; Erdei A; Goldsby RA; Butler JE
    MAbs; 2011; 3(5):431-9. PubMed ID: 22048692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal FcR overexpression boosts humoral immune response in transgenic mice.
    Cervenak J; Bender B; Schneider Z; Magna M; Carstea BV; Liliom K; Erdei A; Bosze Z; Kacskovics I
    J Immunol; 2011 Jan; 186(2):959-68. PubMed ID: 21148035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.
    Lu Y; Vernes JM; Chiang N; Ou Q; Ding J; Adams C; Hong K; Truong BT; Ng D; Shen A; Nakamura G; Gong Q; Presta LG; Beresini M; Kelley B; Lowman H; Wong WL; Meng YG
    J Immunol Methods; 2011 Feb; 365(1-2):132-41. PubMed ID: 21185301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Qualification of a homogeneous cell-based neonatal Fc receptor (FcRn) binding assay and its application to studies on Fc functionality of IgG-based therapeutics.
    Mathur A; Arora T; Liu L; Crouse-Zeineddini J; Mukku V
    J Immunol Methods; 2013 Apr; 390(1-2):81-91. PubMed ID: 23384837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dual Targeting of FcRn and FcγRs
    Monnet C; Jacque E; de Romeuf C; Fontayne A; Abache T; Fournier N; Dupont G; Derache D; Engrand A; Bauduin A; Terrier A; Seifert A; Beghin C; Longue A; Masiello N; Danino L; Nogre M; Raia A; Dhainaut F; Fauconnier L; Togbe D; Reitinger C; Nimmerjahn F; Stevens W; Chtourou S; Mondon P
    Front Immunol; 2021; 12():728322. PubMed ID: 34512662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the interactions of rabbit neonatal Fc receptor (FcRn) with rabbit and human IgG isotypes.
    Szikora B; Hiripi L; Bender B; Kacskovics I; Iliás A
    PLoS One; 2017; 12(9):e0185662. PubMed ID: 28957416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering.
    Wang Y; Tian Z; Thirumalai D; Zhang X
    J Drug Target; 2014 May; 22(4):269-78. PubMed ID: 24404896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune suppression in cynomolgus monkeys by XPro9523: an improved CTLA4-Ig fusion with enhanced binding to CD80, CD86 and neonatal Fc receptor FcRn.
    Bernett MJ; Chu SY; Leung I; Moore GL; Lee SH; Pong E; Chen H; Phung S; Muchhal US; Horton HM; Lazar GA; Desjarlais JR; Szymkowski DE
    MAbs; 2013; 5(3):384-96. PubMed ID: 23549103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells.
    Baker K; Qiao SW; Kuo TT; Aveson VG; Platzer B; Andersen JT; Sandlie I; Chen Z; de Haar C; Lencer WI; Fiebiger E; Blumberg RS
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9927-32. PubMed ID: 21628593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody.
    Monnet C; Jorieux S; Souyris N; Zaki O; Jacquet A; Fournier N; Crozet F; de Romeuf C; Bouayadi K; Urbain R; Behrens CK; Mondon P; Fontayne A
    MAbs; 2014; 6(2):422-36. PubMed ID: 24492301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Murine Neonatal Fc Receptor Is Required for Transport of Immunization-Induced C. difficile-Specific IgG to the Gut and Protection against Disease but Does Not Affect Disease Susceptibility.
    Amadou Amani S; Lang GA; Ballard JD; Lang ML
    Infect Immun; 2021 Sep; 89(10):e0027421. PubMed ID: 34097471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics.
    Piche-Nicholas NM; Avery LB; King AC; Kavosi M; Wang M; O'Hara DM; Tchistiakova L; Katragadda M
    MAbs; 2018 Jan; 10(1):81-94. PubMed ID: 28991504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal Fc receptor and IgG-based therapeutics.
    Kuo TT; Aveson VG
    MAbs; 2011; 3(5):422-30. PubMed ID: 22048693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.